Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Optipharma AS
AS
Active
Org 995227371
Hestehagen 2, 1448
Drøbak
Manufacture of other food products n.e.c.
·
NACE 1089
Est. 2010 · 16 years old
7 employees
Monitor
Share
Norway
/
Companies
/
Manufacture of other food products n.e.c.
/
Optipharma AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
42M
32M
21M
11M
0M
2020: 15M
15M
2020
2021: 22M (+47% vs 2020)
22M
+47%
2021
2022: 24M (+9% vs 2021)
24M
+9%
2022
2023: 32M (+33% vs 2022)
32M
+33%
2023
2024: 34M (+6% vs 2023)
34M
+6%
2024
EBITDA
NOK millions
21M
16M
11M
5M
0M
2020: 5M
5M
2020
2021: 9M (+80% vs 2020)
9M
+80%
2021
2022: 10M (+11% vs 2021)
10M
+11%
2022
2023: 13M (+30% vs 2022)
13M
+30%
2023
2024: 17M (+31% vs 2023)
17M
+31%
2024
Income statement
NOK thousands
Item
2024
2023
2022
2021
2020
Revenue
34 386
32 034
23 991
22 482
15 021
Staff expenses
−3 937
−3 924
−3 901
−2 565
−2 552
EBITDA
16 629
12 797
9 925
9 309
5 105
Depreciation & amort.
−204
−325
−374
−434
−200
EBIT
16 425
12 472
9 551
8 875
4 905
Net financials
445
105
−69
24
−42
Profit before tax
16 870
12 577
9 482
8 899
4 864
Tax
3 716
2 767
2 087
1 958
1 070
Net profit
13 155
9 810
7 395
6 941
3 794
Balance sheet
NOK thousands
Item
2024
2023
2022
2021
2020
Total assets
22 282
20 104
15 141
10 956
8 981
Equity
2 989
1 534
3 524
3 098
1 158
Long-term debt
0
0
0
0
0
Short-term debt
19 293
18 569
11 617
7 857
7 824
Total debt
19 293
18 569
11 617
7 857
7 824
Financial ratios
5-year trend
EBITDA margin
48,4 %
This company
15,8 %
Market median
This company
Market median
206% above market
2020
2024
Equity ratio
13,4 %
This company
38,2 %
Market median
This company
Market median
65% below market
2020
2024
Return on equity
440,1 %
This company
18,4 %
Market median
This company
Market median
>999% above market
2020
2024
Net profit margin
38,3 %
This company
8,1 %
Market median
This company
Market median
373% above market
2020
2024
Asset turnover
1,54×
This company
1,12×
Market median
This company
Market median
37% above market
2020
2024
Debt / equity
6,45×
This company
0,62×
Market median
This company
Market median
940% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on Optipharma AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
